Newgen Software shares drop 5% after Jefferies downgrade to ‘Underperform', cuts target price to Rs 835
Shares of Newgen Software fell 5% in Friday's trade after global brokerage Jefferies downgraded the stock to 'Underperform' from 'Hold' , slashing its target price to ₹835 from ₹965. As of 9:48 AM, the shares were trading 5.04% lower at Rs 973.90.
While the company's Q1 profit came in ahead of estimates, revenue disappointed, dragged by a sharp fall in licence and implementation sales. Jefferies highlighted rising client caution and weaker deal activity as key concerns clouding Newgen's growth visibility.
The brokerage expects margins to remain steady near 25%, but flagged limited upside potential amid a sluggish demand environment. Newgen Software Q1 Results
Newgen Software Technologies reported a weak Q1 FY26, with sequential declines across key metrics, though year-on-year growth remained modest.
Revenue from operations fell 25% QoQ to ₹321 crore, but rose 2% YoY. Total income dropped 21% sequentially to ₹350 crore. EBITDA stood at ₹45 crore, sharply down from ₹137 crore in the previous quarter, with margins contracting to 14.03% from 31.9%.
Profit before tax came in at ₹64 crore, down 55% QoQ, while net profit dropped 54% to ₹50 crore from ₹108 crore in Q4. However, net profit rose 4% YoY.
Total comprehensive income stood at ₹52.74 crore, compared to ₹110.26 crore in Q4 and ₹50.35 crore in Q1 FY25.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
Ahmedabad Plane Crash
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 hours ago
- Yahoo
Jefferies Analyst Prefers Nike Over On: Here's Why
Jefferies analyst Randal J. Konik thinks Nike Inc.'s turnaround is showing more than just a few green shoots — and that could stall On's growth. 'Nike's Vomero Plus is outperforming On's Cloudsurfer Max in both consumer interest and retail sell-through,' he noted in a reports, adding that Google Trends shows 'materially higher search volume for Vomero, signaling stronger buzz.' More from WWD Phil Knight's Record $2 Billion Gift Will Fund Cancer Care and Research in Nike's Portland Community This Italian Performance Brand Wants Your Next Daily Running Shoe to Be Made Out of Natural Fibers Nike's SB Dunk Gets a Plaid-covered Collaboration With Beloved Journalist Nardwuar According to Konik, Nike's new running product is also selling out on reinforcing its broader appeal. 'This momentum aligns with Nike's commentary around a strengthening order book heading into the holiday season,' the analyst concluded. So how does this impact On Holding AG? Nike has ramped up product innovation, particularly in running, and is correcting its wholesale distribution strategy. Both initiatives will present a 'stronger competitive challenge' for On, both in sell-throughs and sell-in dynamics. That could potentially slow On's momentum in key markets, Konik concluded in a report on Thursday. The Jefferies analyst noted that much of On's 'past wholesale growth came while Nike pulled back' its in-store presence. Nike's order book is trending higher as retailers get excite about it new releases. And with On's U.S. door expansion opportunities becoming limited, Konik believes that retailers may decide to allocate more of their open-to-buy budgets to Nike's products. That, in turn, would leave fewer incremental orders for On. 'In short, retail buyer enthusiasm — and dollars — could pivot back to Nike, constraining On's future sell-in growth,' Konik said. On posted second quarter earnings results on Tuesday, reporting a net loss of 40.9 Swiss francs, against net income of 30.8 million Swiss francs a year ago. Net sales grew by 38 percent to 749.2 million Swiss francs, from 567.7 Swiss francs a year ago. The company also raised 2025 guidance following is strong performance for the quarter and what it saw as continued momentum in the first weeks of the third quarter. On also raised guidance in the first quarter following an earnings report that was ahead of expectations. Following On's earnings report, Konik was an outlier among Wall Street analysts, downgrading shares of On to 'Underperform' from a 'Hold' rating in May after the running brand posted first quarter results. He reasoned that 2025 could mark the peak in On's sales growth rate as U.S. door count expansion slows and sell-in moderates in 2026 as retailer orders flow back to Nike. In addition, On's high pricing and narrow product assortment limits its total addressable market, the analyst concluded. According to Konik's On report, a true lifestyle brand has meaningful footwear and apparel sales. Nike has it, while On does not. In addition, 'On's apparel products are highly technical and very expensive, which prevents the category from becoming large in out view,' another factor that limits the brand's total addressable market, he concluded. Wall Street's projecting earnings growth of 20 percent and up, but Konik's not convinced. He noted that On's fixed costs are rising, which can raise execution risk. 'If growth moderates and expenses climb, On may struggle to meet these lofty forecasts, putting pressure on its valuation,' Konik said. Meanwhile, Nike's Vomero 18 has already surpassed the $100 million mark since its February launch, paving the way for a Nike turnaround in the running category. In fact, Nike's confidence of its comeback saw company CEO Elliott Hill tell investors in the firm's fourth quarter earnings conference call in June that the worst was over. 'From here, we expect our business results to improve. It's time to turn the page,' Hill said. Three specialty retailers told Footwear News last month that they too believe that Nike running is on the comeback trail. Best of WWD All the Retailers That Nike Left and Then Went Back Mikey Madison's Elegant Red Carpet Shoe Style [PHOTOS] Julia Fox's Sleekest and Boldest Shoe Looks Over the Years [Photos]
Yahoo
a day ago
- Yahoo
Jefferies Lifts PT on Vistra Corp. (VST) to $241 From $145
Vistra Corp. (NYSE:VST) is one of the best stocks to invest in for beginners. On August 11, Jefferies analyst Julien Dumoulin-Smith raised the firm's price target on Vistra Corp. (NYSE:VST) to $241 from $145, keeping a Buy rating on the shares. Solar panel workers installing a new farm for clean energy generation. The analyst told investors in a research note that the firm is continually seeing value in the shares despite the rally over the past three months. The analyst lifted EBITDA estimates to take into account 'strong' expected free cash flow generation and increased commodity and capacity pricing. Dumoulin-Smith added that the June passing of the Texas SB6 has caused investors to look forward to a Comanche deal announcement. Vistra Corp. (NYSE:VST) provides electricity and power generation. Its operations are divided into the following segments: Retail, Texas, East, West, Sunset, and Asset Closure. While we acknowledge the potential of VST as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a day ago
- Yahoo
Jefferies Reiterates a Buy Rating on Boston Scientific Corporation (BSX), Sets a $130 PT
Boston Scientific Corporation (NYSE:BSX) is one of the best stocks to invest in for beginners. In a report released on August 11, Matthew Taylor from Jefferies reiterated a Buy rating on Boston Scientific Corporation (NYSE:BSX) with a price target of $130.00. A surgeon examining a patient's brain in an operating room, paramedics nearby. The rating update followed the company's release of fiscal Q2 2025 earnings on July 23, with net sales for the quarter reaching $5.061 billion and reflecting a 22.8% growth on a reported basis, 21.6% on an operational basis, and 17.4% on an organic basis, all compared to the prior year period. Boston Scientific Corporation (NYSE:BSX) also reported GAAP net income attributable to common stockholders of $797 million or $0.53 per share (EPS), compared to $324 million or $0.22 per share a year ago. Boston Scientific Corporation (NYSE:BSX) manufactures, develops, and markets medical devices used in interventional medical procedures. Its operations are divided into Cardiovascular and MedSurg segments. The Cardiovascular segment covers Cardiology and Peripheral Interventions, while the MedSurg segment comprises Urology, Endoscopy, and Neuromodulation. While we acknowledge the potential of BSX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
